🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Insurance denied me AGAIN - I am so frustrated Page 5

Insurance denied me AGAIN - I am so frustrated

InsuranceTom Sat, Mar 14, 2026 at 11:39 PM 22 replies 902 viewsPage 5 of 5
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Apr 1, 2026 at 3:24 PM#21

One concrete data point for the thread. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Last edited: Apr 1, 2026 at 9:24 PM
7 5SleepFixSam, PurityPaulOR, MaxMetOK and 4 others
Reply Quote Save Share Report
TomFromTexas
Member
645
2,890
May 2024
Austin, TX
Apr 6, 2026 at 12:51 AM#22

One thing that is still open after Dr.BariatricHTX’s answer:

What would you measure differently if you were starting again?

Last edited: Apr 6, 2026 at 2:51 AM
8 6Dr.NateNeph, PharmD_Rodriguez, julia.endo and 5 others
Reply Quote Save Share Report
GraceAZ_72
Member
156
678
Jan 2025
Tucson, AZ
Apr 10, 2026 at 10:15 AM#23
wendy_avl said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

This is where I part company with the consensus forming above. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

9 7SallyK_inj, CryptoCarl, MariaRD and 6 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
MikeNYC_runner
Member
378
1,678
Jul 2024
New York, NY
Apr 14, 2026 at 7:37 PM#24
wendy_avl said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

10 8GenomicsKate, Dr.ObesityMed, HealthEcon_DC and 7 others
Reply Quote Save Share Report
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Apr 19, 2026 at 4:56 AM#25
wendy_avl said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Adding it to my notes with a link back to this thread.

11 9Dr.PathRoch, mona_PHX, andrew_nyc and 8 others
Reply Quote Save Share Report
1345

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register